Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia–reperfusion
- 1 March 2016
- journal article
- Published by Elsevier in Neuroscience
- Vol. 318, 206-218
Abstract
No abstract availableKeywords
Funding Information
- Japan Science and Technology Agency
- Shin Nippon Biomedical Laboratories, Ltd (SNBL)
- Platform for Drug Discovery, Informatics, and Structural Life Science
- Ministry of Education, Culture, Sports, Science and Technology (MEXT)
This publication has 73 references indexed in Scilit:
- Historical review of thymosin α 1 in infectious diseasesExpert Opinion on Biological Therapy, 2015
- Rational modulation of the innate immune system for neuroprotection in ischemic strokeFrontiers in Neuroscience, 2015
- Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factorExpert Review of Neurotherapeutics, 2014
- Adenovirus-Mediated Prothymosin α Gene Transfer Inhibits the Development of Atherosclerosis in Apoe-Deficient MiceInternational Journal of Biological Sciences, 2014
- Basics and Recent Advances in Peptide and Protein Drug DeliveryTherapeutic Delivery, 2013
- Prothymosin alpha protects cardiomyocytes against ischemia-induced apoptosis via preservation of Akt activationApoptosis, 2013
- Astroglial NF‐κB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injuryJournal of Neurochemistry, 2011
- Astrocytes: Targets for Neuroprotection in StrokeCentral Nervous System Agents in Medicinal Chemistry, 2011
- Data on the Interaction Between Prothymosin α and TLR4 May Help to the Design of New Antiviral CompoundsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in ratsNeurochemistry International, 2011